Synlogic Appoints New CMO, Director; Director Departs
Ticker: SYBX · Form: 8-K · Filed: Dec 23, 2024 · CIK: 1527599
| Field | Detail |
|---|---|
| Company | Synlogic, Inc. (SYBX) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $218,856, $246,213, $350.00, $325,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, board-of-directors
TL;DR
Synlogic brings on a new CMO/Director, Dr. Mulroy, while Dr. Mirabelli exits the board.
AI Summary
On December 17, 2024, Synlogic, Inc. announced changes in its board of directors and executive compensation. Dr. Christopher V. Mirabelli resigned from the Board of Directors, and the company appointed Dr. Robert J. Mulroy as a new Class II director. Additionally, the company entered into an employment agreement with Dr. Mulroy for the position of Chief Medical Officer, effective December 17, 2024.
Why It Matters
The appointment of a new Chief Medical Officer and director suggests a strategic shift or expansion in Synlogic's leadership and medical strategy.
Risk Assessment
Risk Level: medium — Changes in key leadership roles and board composition can indicate strategic shifts or underlying issues within the company.
Key Players & Entities
- Synlogic, Inc. (company) — Registrant
- Christopher V. Mirabelli (person) — Resigning Director
- Robert J. Mulroy (person) — Appointed Director and Chief Medical Officer
- December 17, 2024 (date) — Effective date of appointments and resignation
FAQ
Why did Dr. Christopher V. Mirabelli resign from the Board of Directors?
The filing does not provide a specific reason for Dr. Mirabelli's resignation.
What is the effective date of Dr. Robert J. Mulroy's appointment as a director and Chief Medical Officer?
Dr. Mulroy's appointment as a Class II director and Chief Medical Officer is effective December 17, 2024.
What is Synlogic, Inc.'s principal executive office address?
Synlogic, Inc.'s principal executive offices are located at PO Box 30, Winchester, Massachusetts, 01890.
What is Synlogic, Inc.'s former company name?
Synlogic, Inc.'s former company name was Mirna Therapeutics, Inc., with a name change date of August 9, 2011.
What is the SIC code for Synlogic, Inc.?
The Standard Industrial Classification (SIC) code for Synlogic, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,678 words · 7 min read · ~6 pages · Grade level 13 · Accepted 2024-12-20 20:40:56
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SYBX The NASDAQ Capital M
- $218,856 — all receive a lump-sum payment equal to $218,856, which is equivalent to six months of h
- $246,213 — March 1, 2024 and December 31, 2024, or $246,213. Mr. Awad is also entitled to continued
- $350.00 — any will pay Mr. Awad an hourly rate of $350.00 per hour for such services and will rei
- $325,000 — ny will pay Ms. Dooley a base salary of $325,000 per year, and her target annual bonus i
- $97,500 — ar of 30% of her annual base salary, or $97,500. Ms. Dooley will not be eligible for
Filing Documents
- sybx-20241217.htm (8-K) — 54KB
- 0000950170-24-139249.txt ( ) — 176KB
- sybx-20241217.xsd (EX-101.SCH) — 32KB
- sybx-20241217_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: December 20, 2024 Synlogic, Inc. By: /s/ Mary Beth Dooley Name: Title: Mary Beth Dooley Head of Finance (Principal Financial Officer)